期刊文献+

骨髓增生异常综合征患者骨髓细胞免疫表型研究及意义 被引量:3

Study on the Immunophenotypes of Bone Marrow Cells from Patients with Myelodysplastic Syndromes and Its Clinical Implications
下载PDF
导出
摘要 为探讨骨髓增生异常综合征 (MDS)各亚型的骨髓细胞免疫表型变化及临床意义 ,采用免疫酶标法检测 30例MDS患者各亚型 36例次骨髓细胞抗原的表达 ,并进行临床追踪观察及检测。研究结果表明 ,髓系细胞抗原表达明显异常 ,早期髓系细胞抗原CD13,CD33阳性表达率明显增加 ,较成熟细胞抗原CD15阳性表达率减少 ;单核细胞抗原CD14及淋巴细胞抗原CD7,CD10无显著异常 ,干 /祖细胞抗原CD34在MDS的RAEB/RAEB t组显著增加 ,RA和RAS组则增加不明显 ;早期红系细胞及各增殖期细胞抗原CD71在MDS各亚型均明显高于对照组。结论说明MDS患者骨髓细胞免疫表型存在多系异常 。 The phenotypes of the bone marrow cells in various subtypes of myelodysplastic symdromes (MDS) and its clinical implication were explored. The antigen expression of a panel of antigens expressed in marrow cells from 30 patients with subtypes of MDS were assayed by alkaline phosphatase anti alkaline phosphatase method. The results showed that the expression of myeloid antigens appeared abnormality, CD13 and CD33, found on granulocyte and macrophage precursors, increased, and CD15 decreased. There were no significant changes for monocytic antigen CD14 and lymphoid antigens CD7 and CD10. CD34 was increased in RAEB/RAEB t and was not increased in RA/RAS patients. CD71, expressed by erythroblast and proliferative cells, was higher in all subtypes of MDS than that in control group. It is suggested that the bone marrow cells from MDS patients showed abnormality of more than two series of immunophenotypes, detection of immunophenotype in MDS cells might be contributed to the diagnosis and predicting prognosis.
出处 《中国实验血液学杂志》 CAS CSCD 2002年第2期173-174,共2页 Journal of Experimental Hematology
关键词 骨髓增生异常综合征 骨髓细胞 免疫表型 MDS 免疫酶标法 myelodysplastic syndrome bone marrow cell immunophenotype
  • 相关文献

参考文献3

二级参考文献3

  • 1王志澄 陈璋 等.应用单克隆抗体对慢性淋巴细胞白血病免疫分型的研究[J].中华血液学杂志,1985,6(6):338-341.
  • 2Shao Z H,Chin Med J,1988年,111卷,28页
  • 3王志澄,中华血液学杂志,1985年,6卷,338页

共引文献24

同被引文献29

  • 1吴雨洁,李建勇,仇海荣,肖冰,张建富,宋君红.四色流式细胞术分析骨髓增生异常综合征原始细胞免疫表型[J].中国实验血液学杂志,2006,14(1):50-53. 被引量:14
  • 2王小钦,林果为.282例原发性骨髓增生异常综合征诊断和分型的前瞻性临床研究[J].中华血液学杂志,2006,27(8):546-549. 被引量:34
  • 3BENNETT J M, CATOVSKY D, DANIEL M T, et al. The French-American-British Cooperative Group:Proposals for the classification of the myelodysplastic syndromes[J]. Br J Haematol, 1982, 51:189-199.
  • 4HARRIS N L, JAFFE E S, DIEBOLD J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997[J]. ModPathol, 2000, 13:193-207.
  • 5BENNETT J M. World Health Organization classification of the acute leukemia and myelodysplastic syndrome[J]. Int J Hematol, 2000, 72:131-133.
  • 6JAFFE E S, HARRIS N L, STEIN H, et al. Pathology and genetics of tumors of haematopoietic and lymphoid tissues[M]. Lyon:IARC Press, 2001.61-73.
  • 7MATSUDA A, GERMING U, JINNAI I, et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes [J]. Blood, 2005, 106: 2633-2640.
  • 8BRECCIA M, MENGARELLI A, MANCINI M, et al. Myelodysplastic syndromes in patients under 50 years old: a single institution experience[J]. Leuk Res, 2005, 29:749-754.
  • 9JENSEN I M. Myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry[J]. Leuk lymphoma, 1995, 20:17-25.
  • 10CHANG C C, CLEVLAND R P. Drcreased CD10- positive mature granulocytes in bone marrow from patients with myelodysplastic syndrome[J]. Arch Pathol Lab Med, 2000, 124:1152-1156.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部